This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): Injectable basal long acting insulin
Description: HDV-B compromises the imtermediate-acting and long-acting versions of injectable HDV-I and is designed to provide a once-per-day (or twice-per-day with intermediate-acting) insulin therapy.
Additional information available to subscribers only: